𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Carbohydrates as antigenic determinants of tumor-associated antigens recognized by monoclonal anti-tumor antibodies produced in a syngeneic system

✍ Scribed by Masafumi Ito; Eiji Suzuki; Masaharu Naiki; Fujiro Sendo; Shigeru Arai

Publisher
John Wiley and Sons
Year
1984
Tongue
French
Weight
947 KB
Volume
34
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Two monoclonal antibodies (KH‐1 and KH‐2) against a transplanted fibrosarcoma (KMT‐17) in WKA rats were produced by fusing a mouse myeloma (P~3~‐X63‐Ag8.653) with spleen cells from syngeneic rats hyperimmunized with KMT‐17. Both antibodies showed complement‐dependent cytotoxicity against KMT‐17. By absorption of cytotoxicity, KH‐1 reacted with homologous tumor, other syngeneic fibrosarcomas (KMT‐80 and KMT‐75), and lung and kidney from normal rats. However, KH‐2 reacted with many kinds of tumors and various normal tissues. Antigen specificity was tested by complement fixation and/or solidphase radioimmunoassay using glycolipids isolated from KMT‐17 cells and authentic glycolipids. KH‐1 reacted with globotriglycosyl ceramide which was not detected on KMT‐17 cells and in cross‐reacted weakly with IV^3^‐α‐galactosyl‐lactoneotetraglycosyl ceramide, one of the major glycolipids of KMT‐17. The immune reaction was inhibited by α‐methyl‐galactose. KH‐2 reacted with lactosyl ceramide and lactoneotetraglycosyl ceramide. The reaction was more potently inhibited by lactose than by β‐methyl‐galactose. Antibodies with similar specificity to either KH‐1 or KH‐2 were elevated in syngeneic rat sera after serial immunization with viable KMT‐17 cells.

📜 SIMILAR VOLUMES

Suppression of human melanoma tumor grow
Suppression of human melanoma tumor growth in SCID mice by a human high molecular weight-melanoma associated antigen (HMW-MAA) specific monoclonal antibody
✍ Christine Hafner; Heimo Breiteneder; Soldano Ferrone; Christiane Thallinger; Ste 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 199 KB

## Abstract The lack of efficacy of available therapies for the treatment of malignant melanoma has emphasized the need to develop novel therapeutic strategies to prevent melanoma growth. We have tested whether the anti‐HMW‐MAA mAb 225.28S is able to inhibit human melanoma tumor growth in SCID mice

Detection of a tumor-associated glycopro
Detection of a tumor-associated glycoprotein antigen in serum and urine of melanoma patients by murine monoclonal antibody (AD1-40F4) in enzyme immunoassay
✍ David M. Euhus; Ph.D. Rishab K. Gupta; Donald L. Morton 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

The urine of 68% of melanoma patients contains a high molecular weight glycoprotein which is expressed by melanoma cells and reacts with autologous antibody. Since high levels of this antigen in urine correlate with disease recurrence in surgically treated melanoma patients, it has been termed urina

Serum level of cryptic tumor antigens in
Serum level of cryptic tumor antigens in breast cancer patients as determined by two monoclonal antibodies (m85/f36) and its comparison with ca 15-3
✍ Dr. T. Ming; Rodric Constantine; Takuma Nemoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

An enzyme immunoassay system that measures cryptic epitopes on breast cancer mucinlike antigens (BCM-EIA) was evaluated in a double-blind manner in sera from 58 normal blood donors, 36 sex-and age-matched controls, 36 patients with benign breast diseases, and 47 patients with breast cancer. Two muri